Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1801963rdf:typepubmed:Citationlld:pubmed
pubmed-article:1801963lifeskim:mentionsumls-concept:C0016452lld:lifeskim
pubmed-article:1801963lifeskim:mentionsumls-concept:C0085228lld:lifeskim
pubmed-article:1801963lifeskim:mentionsumls-concept:C0005508lld:lifeskim
pubmed-article:1801963lifeskim:mentionsumls-concept:C1442162lld:lifeskim
pubmed-article:1801963lifeskim:mentionsumls-concept:C1550718lld:lifeskim
pubmed-article:1801963pubmed:issue8lld:pubmed
pubmed-article:1801963pubmed:dateCreated1992-4-28lld:pubmed
pubmed-article:1801963pubmed:abstractTextThe influence of concomitant food intake on plasma concentrations of the antidepressant drug fluvoxamine maleate was investigated in a two-way, crossover study design. Eight male and four female healthy, young volunteers received a single oral dose of fluvoxamine maleate (50 mg, tablet) on two occasions: after an overnight fast and immediately after a breakfast. Food did not affect maximum fluvoxamine plasma levels (Cmax), or the time to reach Cmax (tmax). The plasma AUC of fluvoxamine was on average 7 per cent lower in the fed than in the fasted state. It is concluded that the effect of food on the pharmacokinetics of fluvoxamine is negligible.lld:pubmed
pubmed-article:1801963pubmed:languageenglld:pubmed
pubmed-article:1801963pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801963pubmed:citationSubsetIMlld:pubmed
pubmed-article:1801963pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1801963pubmed:statusMEDLINElld:pubmed
pubmed-article:1801963pubmed:monthNovlld:pubmed
pubmed-article:1801963pubmed:issn0142-2782lld:pubmed
pubmed-article:1801963pubmed:authorpubmed-author:FergusonR KRKlld:pubmed
pubmed-article:1801963pubmed:authorpubmed-author:DobrinskaM...lld:pubmed
pubmed-article:1801963pubmed:authorpubmed-author:RaghoebarMMlld:pubmed
pubmed-article:1801963pubmed:authorpubmed-author:Van BemmelPPlld:pubmed
pubmed-article:1801963pubmed:authorpubmed-author:Van HartenJJlld:pubmed
pubmed-article:1801963pubmed:issnTypePrintlld:pubmed
pubmed-article:1801963pubmed:volume12lld:pubmed
pubmed-article:1801963pubmed:ownerNLMlld:pubmed
pubmed-article:1801963pubmed:authorsCompleteYlld:pubmed
pubmed-article:1801963pubmed:pagination571-6lld:pubmed
pubmed-article:1801963pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1801963pubmed:meshHeadingpubmed-meshheading:1801963-...lld:pubmed
pubmed-article:1801963pubmed:meshHeadingpubmed-meshheading:1801963-...lld:pubmed
pubmed-article:1801963pubmed:meshHeadingpubmed-meshheading:1801963-...lld:pubmed
pubmed-article:1801963pubmed:meshHeadingpubmed-meshheading:1801963-...lld:pubmed
pubmed-article:1801963pubmed:meshHeadingpubmed-meshheading:1801963-...lld:pubmed
pubmed-article:1801963pubmed:meshHeadingpubmed-meshheading:1801963-...lld:pubmed
pubmed-article:1801963pubmed:meshHeadingpubmed-meshheading:1801963-...lld:pubmed
pubmed-article:1801963pubmed:meshHeadingpubmed-meshheading:1801963-...lld:pubmed
pubmed-article:1801963pubmed:year1991lld:pubmed
pubmed-article:1801963pubmed:articleTitleBioavailability of fluvoxamine given with and without food.lld:pubmed
pubmed-article:1801963pubmed:affiliationDepartment of Drug Disposition, Weesp, The Netherlands.lld:pubmed
pubmed-article:1801963pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1801963pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1801963pubmed:publicationTypeRandomized Controlled Triallld:pubmed